Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease
Bylvay missed the study’s primary objective of showing an improvement in native liver survival rates compared to placebo.
Connecting Global Economies
Flash News
Nobel economist on anti-China, anti-science US, AI’s risks
South Korea’s president invokes dramatic Japan realty crash to push domestic property agenda
What Jennifer Lopez Has Said About Her Exes
Remembering Marco Pantani’s record-breaking ascent of Alpe d’Huez
Ipsen Drug Misses Goal in Late-Stage Trial for Rare Liver Disease
Fresh US tariffs on 60 countries; first China duo win Fields Medal: SCMP’s 7 highlights
Volkswagen profit falls, revises down full-year revenue outlook
Madison LeCroy Swears by This Waist-Snatching Amazon Secret
Why Leeds want James Trafford – and why he would be such a key signing
Is London dangerous? Data shows falling crime as mayor takes aim at ‘negative stories’
Friday, July 24, 2026